Skip to main content

Autogenomics Receives ISO Certification

Premium

By Justin Petrone

AutoGenomics said last week that it has received ISO 13485 certification — an International Organization for Standardization standard that covers the requirements for the design and manufacture of medical devices.

TÜV SÜD America, a global inspection firm, was the certification body.

CEO Fareed Kureshy called the certification a "significant milestone" for Autogenomics, which sells a microarray-based molecular diagnostics platform called Infiniti, and has had a number of tests cleared for clinical use in the US and Europe.

In recent years, the Carlsbad, Calif.-based company has had several tests cleared by the US Food and Drug Administration as in vitro diagnostics, including factor II, factor V Leiden, factor II-V Leiden assays for the diagnosis of suspected thrombophilia, as well as an assay for the detection of sensitivity to the anticoagulant drug warfarin..

The company also has 13 CE Marked panels for sale in 15 different countries. According to Kureshy, the recent ISO certification will aid Autogenomics as it "expands its increasing role in the international market."

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.